As a Clinical Scientist at Certara I function as a flexible resource to support the clinical science group as well as other Integrated Drug Development (IDD) functions in support of client projects. I provide assistance to the VP of Clinical Science, Medical Directors, Clinical Operations, and subject matter experts (SME’s) from other IDD functions by providing input into scientific aspects of clinical trial study design and by supporting the scientific writing elements of various clinical technical documents.

Author and manage the development of multiple high quality proposals, budgets and change orders for new business opportunities.Coordinate with internal resources to develop a robust scope of work and competitive budget for proposals.Gather proposal information by identifying sources of information; coordinating submissions and collections.Ensure that all required information is provided in the final proposal within a given time frame for delivery.Work with the business development, project management and scientific teams (as necessary) to ensure the proposal meets the business needs of our clients.Obtain approvals by reviewing proposals with key scientific consultants and management.Look for efficiencies in proposal generation and actively maintain/update Nuventra’s proposal template library with new strategies for positioning Nuventra’s proposals for award.Maintain quality results by using/updating templates; following proposal-writing standards including readability, consistency, and tone.Participate in new client interactions to identify the potential scope of work and overall project needs of the client and translate that into a robust proposal.

Conduct biomedical research in the department of ophthalmology aimed at developing encapsulated cell therapies for the treatment of age-related macular degeneration.

* Managed all proposal requests (RFPs) for a pharmaceutical consulting firm focused on providing exceptional pharmacokinetic and clinical pharmacology services for nonclinical and clinical drug development programs* Worked with senior management, business development, pharmacokineticists, and other key strategy team members to develop quality proposals, budgets and SOWs in response to a wide variety of client requests * Upon contract execution, ensured an efficient and smooth transition to project management and key team members * Acted as a point of contact for clients, vendors and internal team members across multiple projects to ensure timely and thorough completion of projects within anticipated budget expectations* Implemented and maintained a timekeeping system that supported accurate budget tracking on all client projects* Assisted with the development and review of company’s standard operating procedures* Provided oversight and general management of client contracts, proposals and billing

* Work with pharmacokineticists and clinical pharmacology consultants at a project assistant level to finalize PK deliverables for clients. * Assist in development of PK analysis plans and support production of standalone PK reports that can be appended to clinical study reports. * Assist with the preparation, review, QC, and formatting of clinical protocols, clinical study reports, clinical pharmacology strategic plans, INDs, clinical pharmacology and safety sections of NDAs, Investigator Brochures, FDA briefing packets, and other clinical and regulatory documents. * Contribute to clinical pharmacology studies from an operational perspective to assist clients in setting up and executing early phase human trials. * Function as a flexible resource for clients and internal staff. * Assist with or lead project management duties internally or for external clients.

I utilized a variety of physiological and genetic animal models to study the role of cytochrome P450- and cyclooxygenase-derived eicosanoids in cardiovascular and respiratory disease. Examined the preventative and therapeutic efficacy of prostaglandin E2 and iloprost (a stable prostacyclin analog) in a pre-clinical mouse model of bleomycin-induced pulmonary fibrosis.

Used animal (mouse) models to better understand the role of a secreted peptide, called adrenomedullin, in cardiovascular development, physiology, and disease.

Utilized a novel reporter system in Xenopus melanocytes to screen orphan G-protein coupled receptors for ligands as potential therapeutic targets.